RegionInternational. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Research reference — not for sale

Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)

B
lead outcome
Appearance of expression/dynamic wrinkles…
grades vary by outcome ↓
Peptide
also called — Syn-Ake® / SYN®-AKE (trade name, dsm-firmenich, originally Pentapharm) · INCI: Dipeptide Diaminobutyroyl Benzylamide Diacetate (supplied in Glycerin/Aqua) · "snake-venom peptide" · sometimes described as a waglerin-1-mimetic tripeptide. Inspiration molecule: Waglerin-1
cosmeticanti-wrinkle (expression/dynamic lines)muscle-relaxing (topical, biomimetic)smoothing

"Botox from snake venom" — a genuinely beautiful biomimetic story, and a legitimate cosmetic ingredient. Syn-Ake is a rarity in this register: a real, approved cosmetic peptide with a great origin tale and honest topical data — not a gray-market injectable. Three threads: (1) it's inspired by the venom of the Temple Viper, copying a toxin that paralyzes prey — reimagined as a needle-free wrinkle-relaxer; (2) its mechanism is elegant and specific — a reversible block of the muscle acetylcholine receptor, the same idea as Botox but topical and gentle; (3) because it's a cosmetic (topical, appearance-focused), this is exactly the kind of legal-lane ingredient a compliant storefront can actually sell.

In brief

Syn-Ake is a synthetic cosmetic dipeptide with one of skincare's best origin stories: it mimics Waglerin-1, a muscle-paralyzing toxin from the venom of the Temple Viper, reimagined by Swiss chemists (Pentapharm, 2001; now dsm-firmenich) as a needle-free, topical "Botox alternative." Its mechanism is genuinely elegant — it acts as a reversible antagonist of the muscle nicotinic acetylcholine receptor (mnAChR), binding the receptor's ε-subunit to dampen the nerve signal that makes facial muscles contract, so expression lines relax and soften. It's a legitimate, approved cosmetic ingredient (topical, not injected) with real in-vitro and in-vivo data: it reduces muscle-cell contraction substantially in vitro, and clinical cosmetic testing shows visibly reduced wrinkle depth over ~28 days, with good skin tolerance and a reversible effect. The honest framing: it's milder than Botox and works on the look of dynamic (expression) wrinkles, not deep structural ones — and, like all topical "muscle-relaxing" peptides, how much reaches muscle is inherently limited. For this register it's notable as a beautiful biomimetic story AND a genuine legal-lane cosmetic — the kind of ingredient that's actually sellable, honestly, with appearance claims.

Legal standing, by region
European Union
a legal, established cosmetic ingredient (topical), used in

a legal, established cosmetic ingredient (topical), used in finished skincare worldwide under standard cosmetic regulation. This is a cosmetic, not a medicine — no injection, no systemic use.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Appearance of expression/dynamic wrinkles (the cosmetic use)
Solid cosmetic evidence for a topical; effect is mild and gradual, on the look of dynamic lines — not injection-strength
In-vitro: blocks muscle-cell contraction substantially; in-vivo cosmetic testing: visibly reduced wrinkle depth over ~28 days (36-subject studies)
B
Mechanism (mnAChR antagonism)
Mechanism is real and specific; topical delivery to muscle is the limiting factor for magnitude
Well-defined: reversible ε-subunit block, from Waglerin-1 pharmacology (McArdle 1999)
B
"Botox alternative" equivalence
The claim is not baseless: the maker documents reversible mnAChR ε-subunit antagonism modelled on Waglerin-1 (McArdle 1999), substantial in-vitro block of muscle-cell contraction, and 36-subject ~28-day cosmetic testing showing reduced wrinkle depth. But it stays milder, temporary and surface-acting — how much topical peptide reaches muscle is inherently limited, and no trial has compared it head-to-head against injected botulinum toxin. Not equivalent; honest framing needed
Marketing claim
F
Antioxidant (secondary claim)
Minor ancillary property; not the main reason to use it
Dose-dependent DPPH radical scavenging
C
Safety / tolerability (topical)
Good skin compatibility at cosmetic use levels; a topical peptide — not a systemic/injectable exposure
Widely used cosmetic ingredient; reversible action
A
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate) changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Identity

a synthetic cosmetic dipeptide engineered to mimic Waglerin-1, a neuromuscular-blocking toxin from snake venom — reframed as a needle-free, topical "Botox-like" wrinkle-relaxing active. It's a legitimate, widely-used cosmetic ingredient (not a drug, not an injectable), supplied by dsm-firmenich and formulated into serums/creams at low percentages.

Mechanism (as proposed)

at the neuromuscular junction, nerves release acetylcholine, which binds the muscle nicotinic acetylcholine receptor (mnAChR) to open channels, let Na⁺ in, depolarize the muscle, and trigger contraction. Syn-Ake's active dipeptide is a reversible antagonist of this receptor — modeled on Waglerin-1's selective block of the receptor's ε (epsilon) subunit — so it competes with acetylcholine, reduces Na⁺ influx and depolarization, and thereby dampens the micro-contractions of facial mimic muscles. Fewer repeated contractions → relaxed, smoothed expression lines. It's conceptually the same target logic as Botox (both quiet the nerve-to-muscle signal) but by a different, reversible, receptor-level mechanism, delivered topically rather than injected — which is why it's gentler and more gradual.

Related reading

Where Syn-Ake sits among the cosmetic peptides, ranked by evidence, in cosmetic peptides ranked by evidence.

Scan your productSee if Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is in what you're usingOpen the scanner →
Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID71465152
InChIKeyHSUGRPOJOBRRBK-SXBSVMRRSA-N
SMILESCC(=O)O.CC(=O)O.C1C[C@H](N(C1)C(=O)CCN)C(=O)N[C@@H](CCN)C(=O)NCC2=CC=CC=C2
UNII38H206R00R

via PubChem exact-name match (Syn-Ake) · high confidence

Sources — 4 cited
01McArdle JJ, Lentz TL, Witzemann V, et al. Waglerin-1 selectively blocks the epsilon form of the muscle nicotinic acetylcholine receptor. J Pharmacol Exp Ther. 1999 (the toxin pharmacology behind it).
02dsm-firmenich (Pentapharm) SYN-AKE® technical/cosmetic data — mnAChR antagonism; crow's-feet wrinkle-depth reduction over 28 days.
03Debono J, et al. Viper venom botox: the molecular origin and evolution of the waglerin peptides used in anti-wrinkle skin cream. J Mol Evol (biomimetic origin).
04Cosmetic clinical testing (36 subjects, 35–60 yr): reduced wrinkle depth/volume/number over 4 weeks; DPPH antioxidant activity. (Cosmetic ingredient; appearance claims, not medical.)
Updated 2026-07-21 (established cosmetic active; status stable)

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Argireline (Acetyl Hexapeptide-8)C
Peptide
SNAP-8 (Acetyl Octapeptide-3)C
Peptide
Matrixyl (Palmitoyl Pentapeptide-4)B
Peptide
GHK-Cu Peptide (Copper Tripeptide-1)B
Peptide
AHK-Cu (Copper Tripeptide-3)C
Peptide
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen dataBrands
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.